Honar Cherif

Antibiotic-induced microbiome disturbances in hematological patients undergoing hematopoietic stem cell transplantation: a prospective observational study

Montelin, Hanna; Hugerth, Luisa; Debelius, Justine; Melhus, Åsa et al.

2024

Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study

Silfverberg, Thomas; Zjukovskaja, Christina; Ljungman, Per; Nahimi, Adjmal et al.

Ingår i Journal of Neurology, Neurosurgery and Psychiatry, s. 125-133, 2024

• DOI för Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study
• Ladda ner fulltext (pdf) av Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study

Cerebrospinal fluid concentrations of CXCL13 and sCD27 are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis

Lundblad, Katarina; Zjukovskaja, Christina; Larsson, Anders; Cherif, Honar et al.

Ingår i Neurology, 2023

• DOI för Cerebrospinal fluid concentrations of CXCL13 and sCD27 are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis
• Ladda ner fulltext (pdf) av Cerebrospinal fluid concentrations of CXCL13 and sCD27 are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis

Next-generation sequencing of baseline genetic mutations and outcomes of eltrombopag and azacitidine therapy in patients with myelodysplastic syndromes and thrombocytopenia: Data from the SUPPORT clinical trial

Marques Ramos, Pedro; Choi, Jeea; Campbell, Catarina D.; Wang, Ying A. et al.

Ingår i eJHaem, s. 876-881, 2023

• DOI för Next-generation sequencing of baseline genetic mutations and outcomes of eltrombopag and azacitidine therapy in patients with myelodysplastic syndromes and thrombocytopenia: Data from the SUPPORT clinical trial
• Ladda ner fulltext (pdf) av Next-generation sequencing of baseline genetic mutations and outcomes of eltrombopag and azacitidine therapy in patients with myelodysplastic syndromes and thrombocytopenia: Data from the SUPPORT clinical trial

Impact of COVID-19 on patients treated with autologous hematopoietic stem cell transplantation: A retrospective cohort study

Silfverberg, Thomas; Wahlin, Bjorn; Carlson, Kristina; Cherif, Honar

Ingår i Upsala Journal of Medical Sciences, 2022

• DOI för Impact of COVID-19 on patients treated with autologous hematopoietic stem cell transplantation: A retrospective cohort study
• Ladda ner fulltext (pdf) av Impact of COVID-19 on patients treated with autologous hematopoietic stem cell transplantation: A retrospective cohort study

Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study

Silfverberg, Thomas; Zjukovskaja, Christina; Ljungman, Per; Nahimi, Adjmal et al.

Ingår i Journal of Neurology, Neurosurgery and Psychiatry, s. 125-133, 2024

• DOI för Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study
• Ladda ner fulltext (pdf) av Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study

Cerebrospinal fluid concentrations of CXCL13 and sCD27 are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis

Lundblad, Katarina; Zjukovskaja, Christina; Larsson, Anders; Cherif, Honar et al.

Ingår i Neurology, 2023

• DOI för Cerebrospinal fluid concentrations of CXCL13 and sCD27 are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis
• Ladda ner fulltext (pdf) av Cerebrospinal fluid concentrations of CXCL13 and sCD27 are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis

Next-generation sequencing of baseline genetic mutations and outcomes of eltrombopag and azacitidine therapy in patients with myelodysplastic syndromes and thrombocytopenia: Data from the SUPPORT clinical trial

Marques Ramos, Pedro; Choi, Jeea; Campbell, Catarina D.; Wang, Ying A. et al.

Ingår i eJHaem, s. 876-881, 2023

• DOI för Next-generation sequencing of baseline genetic mutations and outcomes of eltrombopag and azacitidine therapy in patients with myelodysplastic syndromes and thrombocytopenia: Data from the SUPPORT clinical trial
• Ladda ner fulltext (pdf) av Next-generation sequencing of baseline genetic mutations and outcomes of eltrombopag and azacitidine therapy in patients with myelodysplastic syndromes and thrombocytopenia: Data from the SUPPORT clinical trial

Impact of COVID-19 on patients treated with autologous hematopoietic stem cell transplantation: A retrospective cohort study

Silfverberg, Thomas; Wahlin, Bjorn; Carlson, Kristina; Cherif, Honar

Ingår i Upsala Journal of Medical Sciences, 2022

• DOI för Impact of COVID-19 on patients treated with autologous hematopoietic stem cell transplantation: A retrospective cohort study
• Ladda ner fulltext (pdf) av Impact of COVID-19 on patients treated with autologous hematopoietic stem cell transplantation: A retrospective cohort study

Biomarkers of demyelination and axonal damage are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis

Zhukovsky, Christina; Larsson, Anders; Cherif, Honar; Kultima, Kim et al.

Ingår i Multiple Sclerosis and Related Disorders, 2022

• DOI för Biomarkers of demyelination and axonal damage are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis
• Ladda ner fulltext (pdf) av Biomarkers of demyelination and axonal damage are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis

Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational study

Zhukovsky, Christina; Sandgren, Sofia; Silfverberg, Thomas; Einarsdottir, Sigrun et al.

Ingår i Journal of Neurology, Neurosurgery and Psychiatry, s. 189-194, 2021

• DOI för Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational study
• Ladda ner fulltext (pdf) av Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational study

Cancer risk in patients with primary immune thrombocytopenia - A Swedish nationwide register study

Ekstrand, Charlotta; Bahmanyar, Shahram; Cherif, Honar; Kieler, Helle et al.

Ingår i Cancer Epidemiology, 2020

• DOI för Cancer risk in patients with primary immune thrombocytopenia - A Swedish nationwide register study
• Ladda ner fulltext (pdf) av Cancer risk in patients with primary immune thrombocytopenia - A Swedish nationwide register study

Patient characteristics when starting treatment and patterns of treatment in adults with chronic immune thrombocytopenia

Ekstrand, Charlotta; Linder, Marie; Cherif, Honar; Kieler, Helle et al.

Ingår i Blood Coagulation and Fibrinolysis, s. 350-356, 2019

• DOI för Patient characteristics when starting treatment and patterns of treatment in adults with chronic immune thrombocytopenia

Patient fick rätt diagnos efter 50 års behandling för immunologisk trombocytopeni – Hade ärftlig trombocytopeni: [Patient was wrongly diagnosed and repeatedly treated for immune thrombocytopenia for 50 years]

Cherif, Honar; Greinacher, Andreas; Lubenow, Norbert

Ingår i Läkartidningen, 2018

Conjugated Pneumococcal Vaccine Triggers a Better Immune Response than Polysaccharide Pneumococcal Vaccine in Patients with Chronic Lymphocytic Leukemia: A Randomized Study by the Swedish CLL group

Svensson, Tobias; Kättström, Magdalena; Hammarlund, Ylva; Roth, Daniel et al.

Ingår i Vaccine, s. 3701-3707, 2018

• DOI för Conjugated Pneumococcal Vaccine Triggers a Better Immune Response than Polysaccharide Pneumococcal Vaccine in Patients with Chronic Lymphocytic Leukemia: A Randomized Study by the Swedish CLL group

Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopenia

Dickinson, Michael; Cherif, Honar; Fenaux, Pierre; Mittelman, Moshe et al.

Ingår i Blood, s. 2629-2638, 2018

• DOI för Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopenia

Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital

Karlsson, Torbjörn; Cherif, Honar

Ingår i Upsala Journal of Medical Sciences, s. 153-157, 2018

• DOI för Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital
• Ladda ner fulltext (pdf) av Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital

Eltrombopag In Combination With Azacitidine For First-Line Treatment Of Mds Patients With Thrombocytopenia: The Randomized, Placebo-Controlled, Phase Iii, Support Study

Dickinson, M.; Cherif, Honar; Fenaux, P.; Mittelman, M. et al.

Ingår i Leukemia Research, 2017

Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed?

Svensson, Tobias; Lundström, Kristina Lamberg; Höglund, Martin; Cherif, Honar

Ingår i Upsala Journal of Medical Sciences, s. 56-60, 2017

• DOI för Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed?
• Ladda ner fulltext (pdf) av Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed?

Pharmacological agents preceding a diagnosis of immune thrombocytopenia in adult patients developing the chronic form: A Swedish national register study

Löfling, Lukas; Linder, Marie; Ekstrand, Charlotta; Cherif, Honar et al.

Ingår i Thrombosis Research, s. 27-31, 2017

• DOI för Pharmacological agents preceding a diagnosis of immune thrombocytopenia in adult patients developing the chronic form: A Swedish national register study
• Ladda ner fulltext (pdf) av Pharmacological agents preceding a diagnosis of immune thrombocytopenia in adult patients developing the chronic form: A Swedish national register study

An open-label phase I dose-finding study of APR-246 in hematological malignancies

Deneberg, S.; Cherif, Honar; Lazarevic, V.; Andersson, P-O et al.

Ingår i Blood Cancer Journal, 2016

• DOI för An open-label phase I dose-finding study of APR-246 in hematological malignancies
• Ladda ner fulltext (pdf) av An open-label phase I dose-finding study of APR-246 in hematological malignancies

Infection and Anti-Infective Treatment Preceding a Diagnosis of Primary Persisting Immune Thrombocytopenia

Sohrabian, Donia; Linder, Marie; Ekstrand, Charlotta; Cherif, Honar et al.

Ingår i Pharmacoepidemiology and Drug Safety, s. 88-88, 2016

• DOI för Infection and Anti-Infective Treatment Preceding a Diagnosis of Primary Persisting Immune Thrombocytopenia

Characteristics of Patients at Initiation of Treatment for Primary Chronic Immune Thrombocytopenia

Ekstrand, Charlotta; Linder, Marie; Cherif, Honar; Kieler, Helle et al.

Ingår i Pharmacoepidemiology and Drug Safety, s. 197-197, 2016

• DOI för Characteristics of Patients at Initiation of Treatment for Primary Chronic Immune Thrombocytopenia

General Pharmacological Treatments Preceding A Primary Chronic Immune Thrombocytopenia Diagnosis

Lofling, Lukas; Linder, Marie; Ekstrand, Charlotta; Cherif, Honar et al.

Ingår i Pharmacoepidemiology and Drug Safety, s. 645-646, 2016

• DOI för General Pharmacological Treatments Preceding A Primary Chronic Immune Thrombocytopenia Diagnosis

Effect of intravenous iron supplementation on iron stores in non-anemic iron-deficient patients with hereditary hemorrhagic telangiectasia

Karlsson, Torbjörn; Cherif, Honar

Ingår i Hematology Reports, 2016

• DOI för Effect of intravenous iron supplementation on iron stores in non-anemic iron-deficient patients with hereditary hemorrhagic telangiectasia
• Ladda ner fulltext (pdf) av Effect of intravenous iron supplementation on iron stores in non-anemic iron-deficient patients with hereditary hemorrhagic telangiectasia

Increased susceptibility to infections before the diagnosis of immune thrombocytopenia

Ekstrand, C.; Linder, M.; Cherif, Honar; Kieler, H. et al.

Ingår i Journal of Thrombosis and Haemostasis, s. 807-814, 2016

• DOI för Increased susceptibility to infections before the diagnosis of immune thrombocytopenia

Increased Anti-infective Treatments Preceding a Diagnosis of Primary Immune Thrombocytopenia

Ekstrand, Charlotta; Linder, Marie; Cherif, Honar; Kieler, Helle et al.

Ingår i Pharmacoepidemiology and Drug Safety, s. 411-412, 2015

Susceptibility to Infection before Diagnosis of Primary Chronic Immune Thrombocytopenia

Ekstrand, Charlotta; Linder, Marie; Cherif, Honar; Kieler, Helle et al.

Ingår i Pharmacoepidemiology and Drug Safety, s. 519-519, 2015

Combination treatment with an erythropoiesis-stimulating agent and intravenous iron alleviates anaemia in patients with hereditary haemorrhagic telangiectasia

Cherif, Honar; Karlsson, Torbjörn

Ingår i Upsala Journal of Medical Sciences, s. 350-353, 2014

• DOI för Combination treatment with an erythropoiesis-stimulating agent and intravenous iron alleviates anaemia in patients with hereditary haemorrhagic telangiectasia

A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine

Svensson, Tobias; Chowdhury, Onima; Garelius, Hege; Lorenz, Fryderyk et al.

Ingår i European Journal of Haematology, s. 439-445, 2014

• DOI för A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine

Clinical experience of granulocyte transfusion in the management of neutropenic patients with haematological malignancies and severe infection

Cherif, Honar; Axdorph, Ulla; Kalin, Mats; Björkholm, Magnus

Ingår i Scandinavian Journal of Infectious Diseases, s. 112-116, 2013

• DOI för Clinical experience of granulocyte transfusion in the management of neutropenic patients with haematological malignancies and severe infection

Adjuvanted influenza a (H1N1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy-treated patients

Cherif, Honar; Höglund, Martin; Pauksens, Karlis

Ingår i European Journal of Haematology, s. 413-419, 2013

• DOI för Adjuvanted influenza a (H1N1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy-treated patients

Clinical significance of serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukemia

Svensson, Tobias; Höglund, Martin; Cherif, Honar

Ingår i Scandinavian Journal of Infectious Diseases, s. 537-542, 2013

• DOI för Clinical significance of serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukemia

Answer to "Letter to the Editor, Scandinavian Journal of Infectious Diseases"

Svensson, Tobias; Cherif, Honar; Höglund, Martin

Ingår i Scandinavian Journal of Infectious Diseases, s. 730-730, 2013

• DOI för Answer to "Letter to the Editor, Scandinavian Journal of Infectious Diseases"

Hematological: Low all-cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single-center study

Kjellander, Christian; Bjorkholm, Magnus; Cherif, Honar; Kalin, Mats et al.

Ingår i European Journal of Haematology, s. 422-430, 2012

• DOI för Hematological: Low all-cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single-center study

Targeting p53 in Vivo: a First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer

Lehmann, Sören; Bykov, Vladimir J N; Ali, Dina; Andrén, Ove et al.

Ingår i Journal of Clinical Oncology, s. 3633-3639, 2012

• DOI för Targeting p53 in Vivo: a First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer

Influenza A H1N1 2009 Vaccine in Patients with Hematological Diseases: Good Safety and Immunogenicity Even in Heavily Chemotherapy-Treated Patients

Cherif, Honar; Höglund, Martin; Pauksens, Karlis

Ingår i Blood, s. 1054, 2012

Antibiotic-induced microbiome disturbances in hematological patients undergoing hematopoietic stem cell transplantation: a prospective observational study

Montelin, Hanna; Hugerth, Luisa; Debelius, Justine; Melhus, Åsa et al.

2024